Weight Gain in Type 2 Diabetes Mellitus Patients Receiving Sulfonylurea Medications at a Tertiary Hospital in Surabaya, Indonesia
Downloads
Introduction: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by persistent hyperglycemia. The prevalence of diabetes in Indonesia is 1.5%, although East Java recorded a 2.1% rate in 2013. T2DM medications, such as sulfonylureas, may lead to hypoglycemia and weight gain. This study aimed to investigate the weight gain effects of sulfonylureas in T2DM patients at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
Methods: This retrospective cross-sectional study used retrograde anamnesis on 41 T2DM patients receiving sulfonylurea medications for the preceding six months. The data were collected from medical records and interviews with the T2DM patients who received treatment at the Internal Medicine Clinic of Dr. Soetomo General Academic Hospital from January to June 2022.
Results: Most patients were 46–65 years old (73.2%), female (51.2%), and had been diabetic for over 15 years (48.8%). The predominant medications administered to the patients were glimepiride (41.4%) and a combination of glibenclamide 5 mg, metformin 500 mg, and acarbose 100 mg (19.5%). Almost all patients took their medications in the morning before meals (92.6%). The average weight gain was 4.6 kg, with the glibenclamide and metformin combination resulting in a 17% incidence.
Conclusion: T2DM patients who use sulfonylureas generally gain weight and exhibit specific traits, including being middle-aged, female, and diabetic for multiple years. The most commonly used sulfonylureas are glimepiride for monotherapy and glibenclamide for combination therapy with metformin and acarbose. Future research is required to understand weight gain in T2DM patients treated with sulfonylureas more comprehensively.
Highlights:
- This study investigated weight changes in type 2 diabetes mellitus (T2DM) patients receiving sulfonylureas, with a special focus on the emergence of weight gain as a new problem in T2DM management.
- The importance of this study pertains to its findings regarding weight gain in T2DM patients treated with sulfonylureas, offering additional data that aids in preventing adverse effects of the medications.
Akrom A, Sari OM, Urbayatun S, Saputri Z (2019). Analisis determinan faktor-faktor yang berhubungan dengan kepatuhan minum obat pasien diabetes tipe 2 di pelayanan kesehatan primer. Jurnal Sains Farmasi & Klinis 6(1): 54. doi: 10.25077/jsfk.6.1.54-62.2019.
Ali J, Haider SMS, Ali SM, Haider T, Anwar A, et al. (2023). Overall clinical features of type 2 diabetes mellitus with respect to gender. Cureus 15(3): e35771. doi: 10.7759/cureus.35771.
American Diabetes Association (2022). Classification and diagnosis of diabetes: Standards of medical care in diabetes—2022. Diabetes Care 45 (Supplement_1): S17–S38. doi: 10.2337/dc22-S002.
Annisa BS, Puspitasari CE, Aini SR (2021). Profil penggunaan obat antidiabetes pada pasien diabetes mellitus tipe 2 di instalasi rawat jalan RSUD Provinsi NTB tahun 2018. Sasambo Journal of Pharmacy 2(1): 37–41. doi: 10.29303/sjp.v2i1.74.
Apovian CM, Okemah J, O’Neil PM (2019). Body weight considerations in the management of type 2 diabetes. Advances in Therapy 36(1): 44–58. doi: 10.1007/s12325-018-0824-8.
Aranaz-Andrés JM, Limón-Ramírez R, Aibar-Remón C, Gea-Velázquez de Castro MT, Bolúmar F, et al. (2017). Comparison of two methods to estimate adverse events in the IBEAS Study (Ibero-American study of adverse events): Cross-sectional versus retrospective cohort design. BMJ Open 7(10): e016546. doi: 10.1136/bmjopen-2017-016546.
Bai JR, Mukherjee DV, Befus M, Apa Z, Lowy FD, et al. (2014). Concordance between medical records and interview data in correctional facilities. BMC Medical Research Methodology 14(1): 50. doi: 10.1186/1471-2288-14-50.
Bidulang CB, Wiyono WI, Mpila DA (2021). Evaluasi tingkat kepatuhan penggunaan obat antidiabetik pada pasien diabetes melitus tipe 2 di Puskesmas Enemawira. Pharmacon 10(3): 1066–1071. Retrieved from https://ejournal.unsrat.ac.id/v3/index.php/pharmacon/article/view/35611.
Boku A (2019). Faktor-faktor yang berhubungan terhadap kadar gula darah pada penderita diabetes melitus tipe II di RS PKU Muhammadiyah Yogyakarta. Universitas ’Aisyiyah Yogyakarta. Retrieved from https://digilib.unisayogya.ac.id/4586/.
Confederat L, Ștefan R, Lupaşcu F, Constantin S, Avram I, et al. (2016). Side effects induced by hypoglycaemic sulfonylureas to diabetic patients – A retrospective study. Farnacia 64(5): 677. Retrieved from https://farmaciajournal.com/issue-articles/side-effects-induced-by-hypoglycaemic-sulfonylureas-to-diabetic-patients-a-retrospective-study/.
Costello R, Nicolas S, Shivkumar A (2023). Sulfonylureas. Treasure Island, FL: StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK513225/.
de Ritter R, de Jong M, Vos RC, van der Kallen CJH, Sep SJS, et al. (2020). Sex differences in the risk of vascular disease associated with diabetes. Biology of Sex Differences 11(1): 1. doi: 10.1186/s13293-019-0277-z.
Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, et al. (2020). Pathophysiology of type 2 diabetes mellitus. International Journal of Molecular Sciences 21(17): 6275. doi: 10.3390/ijms21176275.
Ganesan K, Rana M, Sultan S (2023). Oral hypoglycemic medications. Treasure Island, FL: StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK482386/.
Genuth S, Palmer J, Nathan D (2018). Classification and diagnosis of diabetes. In: Diabetes in America (Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, et al. eds). Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, 3rd ed. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK568014/.
Goyal R, Singhal M, Jialal I (2023). Type 2 diabetes. Treasure Island, FL: StatPearls Publishing. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/29219149.
Hardin M, Jacobs T (2023). Glyburide. Treasure Island, FL: StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK545313/.
Isnaini N, Ratnasari R (2018). Faktor risiko mempengaruhi kejadian diabetes mellitus tipe dua. Jurnal Kebidanan dan Keperawatan Aisyiyah 14(1): 59–68. doi: 10.31101/jkk.550.
Jonathan K, Kuswinarti, Mulyani SNN (2019). Pola penggunaan antidiabetes oral pasien diabetes melitus tipe 2 di Bagian Penyakit Dalam RSUD Kota Bandung Tahun 2017. Cermin Dunia Kedokteran 46(6): 407–413. Retrieved from https://cdkjournal.com/index.php/CDK/article/view/433.
Kalra S, Bahendeka S, Sahay R, Ghosh S, Md F, et al. (2018). Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of type 2 diabetes mellitus – International Task Force. Indian Journal of Endocrinology and Metabolism 22(1): 132. doi: 10.4103/ijem.IJEM_556_17.
Karamoy AB, Dharmadi M (2019). Kadar glukosa darah pada pasien diabetes mellitus tipe 2 yang berolahraga rutin dan yang berolahraga tidak rutin di Lapangan Renon, Denpasar 2015. Jurnal Medika Udayana 8(4). Retrieved from https://ojs.unud.ac.id/index.php/eum/article/view/50052.
Khairinnisa A, Yusmaini H, Hadiwiardjo YH (2020). Perbandingan penggunaan glibenclamid-metformin dan glimepirid-metformin terhadap efek samping hipoglikemia pasien diabetes melitus tipe-2 di Kota Tangerang Selatan bulan Januari – Oktober tahun 2019. In: Seminar Nasional Riset Kedokteran (Sensorik). Retrieved from https://conference.upnvj.ac.id/index.php/sensorik/article/view/448.
Komariah K, Rahayu S (2020). Hubungan usia, jenis kelamin dan indeks massa tubuh dengan kadar gula darah puasa pada pasien diabetes melitus tipe 2 di Klinik Pratama Rawat Jalan Proklamasi, Depok, Jawa Barat. Jurnal Kesehatan Kusuma Husada 11(1): 41–50. doi: 10.34035/jk.v11i1.412.
Kurniawan I (2010). Diabetes melitus tipe 2 pada usia lanjut. Journal of the Indonesian Medical Association 60(12): 576–584. Retrieved from http://perpus.stikep-ppnijabar.ac.id/index.php?p=show_detail&id=1991.
Martins WHB, Sutriningsih A, Dewi N (2018). Pengaruh konseling aktivitas fisik dan pola makan terhadap perubahan IMT pada penderita diabetes mellitus di Puskesmas Dinoyo Kecamatan Lowokwaru Kota Malang. Nursing News Jurnal Ilmiah Keperawatan 3(1): 191–203. Retrieved from https://publikasi.unitri.ac.id/index.php/fikes/article/view/765.
Murwati IS, Murtisiwi L (2021). Identifikasi potensi interaksi obat pada peresepan pasien rawat jalan diabetes melitus tipe 2 dengan hipertensi di RSUD dr. Soediran Mangun Sumarso Wonogiri. Jurnal Farmasi (Journal of Pharmacy) 10(1): 38–45. doi: 10.37013/jf.v10i1.119.
Nasution F, Andilala A, Siregar AA (2021). Faktor risiko kejadian diabetes mellitus. Jurnal Ilmu Kesehatan 9(2): 94. doi: 10.32831/jik.v9i2.304.
Pelawi NG, Fauzia D (2022). Pola penggunaan obat antidiabetik oralpada pasien diabetes melitus tipe 2 di Puskesmas Tenayan Raya Kota Pekan Baru. Jurnal Kedokteran Syiah Kuala 22(4): 207–212. Retrieved from https://jurnal.usk.ac.id/JKS/article/view/22763.
Purwakanthi A, Shafira NNA, Harahap H, Kusdiyah E (2020). Gambaran penggunaan obat diabetes mellitus pada pasien diabetes mellitus tipe 2. Jambi Medical Journal: Jurnal Kedokteran Dan Kesehatan 8(1): 40–46. doi: 10.22437/jmj.v8i1.9483.
Reddy AT, Reddy BV, Shanthi G, Shirisha A, Reddy NSS (2022). A review on recent trends of diabetes mellitus. Journal of Innovations in Applied Pharmaceutical Science (JIAPS) 7(1): 1–9. doi: 10.37022/jiaps.v7i1.258.
Rejeski WJ, Ip EH, Bertoni AG, Bray GA, Evans G, et al. (2012). Lifestyle change and mobility in obese adults with type 2 diabetes. New England Journal of Medicine 366(13): 1209–1217. doi: 10.1056/NEJMoa1110294.
Rita N (2018). Hubungan jenis kelamin, olah raga dan obesitas dengan kejadian diabetes mellitus pada lansia. JIK - Jurnal Ilmu Kesehatan 2(1): 93–100. doi: 10.33757/jik.v2i1.52.
Sabilla M, Mustakim, Sukma F, Ariasih RA, Efendi R, et al. (2020). Community services in pandemic situation: Preparing quality of life in middle age group through social media education “Kulwap” (Kuliah Whatsapp). In: The 4th International Conference on Health. Fakultas Ilmu Kesehatan, Universitas Dehasen Bengkulu. Retrieved from https://proceeding.unived.ac.id/index.php/univedich/article/view/15.
Simanjuntak GV, Simamora M (2020). Lama menderita diabetes mellitus tipe 2 sebagai faktor risiko neuropati perifer diabetik. Holistik Jurnal Kesehatan 14(1): 96–100. Retrieved from https://www.ejurnalmalahayati.ac.id/index.php/holistik/article/view/1810/pdf.
Soelistijo SA, Lindarto D, Decroli E, Permana H, Sucipto KW, et al. (2021). Pedoman pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia 2021. Indonesian Society of Endocrinology. Retrieved from https://pbperkeni.or.id/wp-content/uploads/2021/11/22-10-21-Website-Pedoman-Pengelolaan-dan-Pencegahan-DMT2-Ebook.pdf.
Sujayanti LGT, Kurnianta PDM (2022). Pola penggunaan antidiabetes oral pada pasien diabetes melitus tipe II di Rumah Sakit X Gianyar. Jurnal Ilmiah Mahaganesha 1(1): 12–17. Retrieved from https://ojs.farmasimahaganesha.ac.id/index.php/JIM/article/view/44/43.
Taborat M (2023). Potensi interaksi obat pada resep pasien diabetes melitus rawat jalan di Rumah Sakit Divari Medical Center Manokwari 2020. Health Information: Jurnal Penelitian 15(1). doi: 10.36990/hijp.v15i1.640.
Trerattanavong K, Tadi P (2023). Glimepiride. Treasure Island, FL: StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK554600/.
Utomo AA, Rachmawati AA, Rahmah S, Amalia R (2020). Faktor risiko diabetes mellitus tipe 2: A systematic review. An-Nur: Jurnal Kajian dan Pengembangan Kesehatan Masyarakat 1(1): 45–53. Retrieved from https://jurnal.umj.ac.id/index.php/AN-NUR/article/view/7132.
Wang Y, Perri M (2018). A systematic review of patient-reported satisfaction with oral medication therapy in patients with type 2 diabetes. Value in Health 21(11): 1346–1353. doi: 10.1016/j.jval.2018.05.001.
Widiasari KR, Wijaya IMK, Suputra PA (2021). Diabetes melitus tipe 2: Faktor risiko, diagnosis, dan tatalaksana. Ganesha Medicine 1(2): 114–120. doi: 10.23887/gm.v1i2.40006.
Wijaya IN, Faturrohmah A, Agustin WW, Soesanto TG, Kartika D, et al. (2015a). Profil kepatuhan pasien diabetes melitus puskesmas wilayah Surabaya Timur dalam menggunakan obat dengan metode pill count. Jurnal Farmasi Komunitas 2(1): 18–22. Retrieved from https://journal.unair.ac.id/download-fullpapers-jfkb5969c2ab7full.pdf.
Wijaya IN, Faturrohmah A, Yuda A, Mufarrihah, Soesanto TG, et al. (2015b). Profil penggunaan obat pada pasien diabetes melitus di puskesmas wilayah Surabaya Timur. Jurnal Farmasi Komunitas 2(1): 23–28. Retrieved from https://journal.unair.ac.id/download-fullpapers-jfk0ef08559fe2full.pdf.
Wikannanda IAAD, Sari NLPEK, Aryastuti AASA (2023). Gambaran penggunaan terapi kombinasi oral metformin-sulfonylurea pada pasien DM tipe 2 di Denpasar. AMJ Aesculapius Medical Journal 3(2): 224–232. Retrieved from https://ejournal.warmadewa.ac.id/index.php/amj/article/view/5407.
Yuliani F, Oenzil F, Iryani D (2014). Hubungan berbagai faktor risiko terhadap kejadian penyakit jantung koroner pada penderita diabetes melitus tipe 2. Jurnal Kesehatan Andalas 3(1): 37–40. doi: 10.25077/jka.v3i1.22.
Yuswantina R, Dyahariesti N (2018). Analisis efektivitas biaya penggunaan antidiabetes oral tunggal dan kombinasi pada pasien BPJS penderita diabetes millitus tipe 2 di Rumah Sakit X. Media Farmasi Indonesia 13(1). Retrieved from https://mfi.stifar.ac.id/MFI/article/view/47.
Copyright (c) 2025 Ghagat Dresta Putra Respati, Jongky Hendro Prajitno, Rosy Setiawati, Rio Wironegoro
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) Author
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).
